Virax Biolabs Group Stock Target Price
| VRAX Stock | USD 1.97 0.10 4.83% |
Virax Biolabs Group fundamentals help investors to digest information that contributes to Virax Biolabs' financial success or failures. It also enables traders to predict the movement of Virax Stock. The fundamental analysis module provides a way to measure Virax Biolabs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virax Biolabs stock.
Virax | Target Price |
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Virax Biolabs ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Virax Biolabs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Virax Biolabs' managers, analysts, and investors.Environmental | Governance | Social |
Virax Fundamentals
| Return On Equity | -0.96 | ||||
| Return On Asset | -0.5 | ||||
| Operating Margin | (42.54) % | ||||
| Current Valuation | 2.08 M | ||||
| Shares Outstanding | 4.34 M | ||||
| Shares Owned By Insiders | 7.06 % | ||||
| Shares Owned By Institutions | 5.37 % | ||||
| Number Of Shares Shorted | 284.03 K | ||||
| Price To Book | 1.04 X | ||||
| Price To Sales | 57.46 X | ||||
| Revenue | 156.42 K | ||||
| Gross Profit | (1.36 K) | ||||
| EBITDA | (6.61 M) | ||||
| Net Income | (6.74 M) | ||||
| Cash And Equivalents | 21.76 K | ||||
| Total Debt | 224.3 K | ||||
| Current Ratio | 0.04 X | ||||
| Book Value Per Share | 2.08 X | ||||
| Cash Flow From Operations | (6.25 M) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | (2.61) X | ||||
| Target Price | 20.0 | ||||
| Number Of Employees | 17 | ||||
| Beta | 1.93 | ||||
| Market Capitalization | 8.99 M | ||||
| Total Asset | 5.48 M | ||||
| Retained Earnings | (18.53 M) | ||||
| Working Capital | 4.21 M | ||||
| Net Asset | 5.48 M |
About Virax Biolabs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virax Biolabs Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virax Biolabs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virax Biolabs Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.